人神经干细胞的研究进展及应用前景.pdfVIP

2008年 7 川 Medical Recapitulate． JIll 2008．Vo1．14．No．13 · 1949· 8O91-8099． [18] Suleimani YM．Walker MJ．Allergic rhiIlitis and its pharmacology [11] Ippoliti F，De Santis W。Volterrani A．et a1．Immunomodulati0n 【J]．Phaxmacotherapy，2007，ll4：233-260． during sublingual therapy in allergic children[JJ．Pediatr Allergy [19] Passalaqua G，Canonica GW．Long-lasting clinical efficacy ofaller- Immunol，2003。14(3)：216-221． gen specific immunotherapy[J]．Allergy，2002。57(4)：275-276． 王少圣，周书林．哮喘特异性免疫治疗给药方法的研究现状 [2O] S pak JM，Matsui EC，Mudd K，et a1．The natural history of IgE． [J]．医学综述，2006，12(21)：1327．1329． mediated cow s milk allergy[J]．J Allergy Clin Immunol，2007． Kline JN．Immunotherapy of asthma using CpG oligodeoxynucleoti． 120(5)：l172—1177． des[J]．Immunol Res，2007，39(1／3)：279-286． [21] Passalacqua G，Durham SR．Alle蛹c Rhinitis and its impact on Kline JN，Kitagaki K，Businga TR。et a1．Treatment of established asthma upaate：allergen immunotherapy[J]．J Allergy Clin Immu． asthma in a murine model using CpG oligodeoxynucleotides[J]． nol，2007，119(4)：881-891． Physiol Lung Cell Mol Physiol，2002， 283(1)：170．179． [22] Hayashi T，Hasegawa K，Sasaki Y．Systemic administration of oly． [15] Kitagaki K，Businga TR，Kline JN．Oral administration of CpG． godeoxynucleotides with CpG motifs at priming phase reduces local ODNs suppresses antigen-induced asthma in mice[J]．Clin Ex Im． Th2 response and late allergic rhinitis in B^IB／c mice『J1．IⅡ- munol，2006，143(2)：249-259． flammation，2008，31(1)：47-56． [16] Preston JA，Essilfie AT，Horvat JC．et a1．Inhibition of allergic air- [23] Natio K．Clinical features oflaryngeal allergy and its mechanisms of ways disease by immunomodulatory therapy w